Patrik Brundin - Publications

Lund University, Lund, Skåne län, Sweden 

325 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Stott SRW, Wyse RK, Brundin P. Drug Repurposing for Parkinson's Disease: The International Linked Clinical Trials experience. Frontiers in Neuroscience. 15: 653377. PMID 33815053 DOI: 10.3389/fnins.2021.653377  0.56
2021 Bergkvist L, Johnson ME, Mercado G, Steiner JA, Meyerdirk L, Schulz E, Madaj Z, Ma J, Becker K, Li Y, Brundin P. An extended release GLP-1 analogue increases α-synuclein accumulation in a mouse model of prodromal Parkinson's disease. Experimental Neurology. 113693. PMID 33727096 DOI: 10.1016/j.expneurol.2021.113693  0.68
2021 George S, Tyson T, Rey NL, Sheridan R, Peelaerts W, Becker K, Schulz E, Meyerdirk L, Burmeister AR, von Linstow CU, Steiner JA, Escobar Galvis ML, Ma J, Pospisilik A, Labrie V, ... ... Brundin P, et al. T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils. Journal of Parkinson's Disease. PMID 33579871 DOI: 10.3233/JPD-202351  0.68
2020 Kulkarni AS, Del Mar Cortijo M, Roberts ER, Suggs TL, Stover HB, Pena-Bravo JI, Steiner JA, Luk KC, Brundin P, Wesson DW. Perturbation of in vivo Neural Activity Following α-Synuclein Seeding in the Olfactory Bulb. Journal of Parkinson's Disease. PMID 32925105 DOI: 10.3233/JPD-202241  0.68
2020 Stott SRW, Wyse RK, Brundin P. Novel approaches to counter protein aggregation pathology in Parkinson's disease. Progress in Brain Research. 252: 451-492. PMID 32247372 DOI: 10.1016/bs.pbr.2019.10.007  0.56
2020 Espay AJ, Kalia LV, Gan-Or Z, Williams-Gray CH, Bedard PL, Rowe SM, Morgante F, Fasano A, Stecher B, Kauffman MA, Farrer MJ, Coffey CS, Schwarzschild MA, Sherer T, Postuma RB, ... ... Brundin P, et al. Disease modification and biomarker development in Parkinson disease: Revision or reconstruction? Neurology. PMID 32102975 DOI: 10.1212/Wnl.0000000000009107  0.72
2019 Rey NL, Bousset L, George S, Madaj Z, Meyerdirk L, Schulz E, Steiner JA, Melki R, Brundin P. α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb. Acta Neuropathologica Communications. 7: 221. PMID 31888771 DOI: 10.1186/s40478-019-0859-3  0.68
2019 George S, Rey NL, Tyson T, Esquibel C, Meyerdirk L, Schulz E, Pierce S, Burmeister AR, Madaj Z, Steiner JA, Escobar Galvis ML, Brundin L, Brundin P. Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson's disease. Molecular Neurodegeneration. 14: 34. PMID 31419995 DOI: 10.1186/s13024-019-0335-3  0.68
2019 Chatterjee D, Sanchez DS, Quansah E, Rey NL, George S, Becker K, Madaj Z, Steiner JA, Ma J, Escobar Galvis ML, Kordower JH, Brundin P. Loss of One Engrailed1 Allele Enhances Induced α-Synucleinopathy. Journal of Parkinson's Disease. PMID 30932894 DOI: 10.3233/Jpd-191590  0.68
2018 Graham SF, Rey NL, Ugur Z, Yilmaz A, Sherman E, Maddens M, Bahado-Singh RO, Becker K, Schulz E, Meyerdirk LK, Steiner JA, Ma J, Brundin P. Metabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson's Disease. Metabolites. 8. PMID 30384419 DOI: 10.3390/metabo8040071  0.68
2018 Quansah E, Peelaerts W, Langston JW, Simon DK, Colca J, Brundin P. Targeting energy metabolism via the mitochondrial pyruvate carrier as a novel approach to attenuate neurodegeneration. Molecular Neurodegeneration. 13: 28. PMID 29793507 DOI: 10.1186/s13024-018-0260-x  0.4
2018 Graham SF, Rey NL, Yilmaz A, Kumar P, Madaj Z, Maddens M, Bahado-Singh RO, Becker K, Schulz E, Meyerdirk LK, Steiner JA, Ma J, Brundin P. Biochemical profiling of the brain and blood metabolome in a mouse model of prodromal Parkinson's disease reveal distinct metabolic profiles. Journal of Proteome Research. PMID 29762036 DOI: 10.1021/acs.jproteome.8b00224  0.68
2018 Steiner JA, Quansah E, Brundin P. The concept of alpha-synuclein as a prion-like protein: ten years after. Cell and Tissue Research. PMID 29480459 DOI: 10.1007/s00441-018-2814-1  0.68
2017 Walsh RR, Krismer F, Galpern WR, Wenning GK, Low PA, Halliday G, Koroshetz WJ, Holton J, Quinn NP, Rascol O, Shaw LM, Eidelberg D, Bower P, Cummings JL, Abler V, ... ... Brundin P, et al. Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting. Neurology. PMID 29237794 DOI: 10.1212/Wnl.0000000000004798  0.4
2017 Rey NL, George S, Steiner JA, Madaj Z, Luk KC, Trojanowski JQ, Lee VM, Brundin P. Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term. Acta Neuropathologica. PMID 29209768 DOI: 10.1007/S00401-017-1792-9  0.68
2017 Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE. Parkinson disease. Nature Reviews. Disease Primers. 3: 17013. PMID 28332488 DOI: 10.1038/nrdp.2017.13  0.4
2016 Ghosh A, Tyson T, George S, Hildebrandt EN, Steiner JA, Madaj Z, Schulz E, Machiela E, McDonald WG, Escobar Galvis ML, Kordower JH, Van Raamsdonk JM, Colca JR, Brundin P. Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's disease. Science Translational Medicine. 8: 368ra174. PMID 27928028 DOI: 10.1126/Scitranslmed.Aag2210  0.68
2016 Kurowska Z, Jewett M, Brattås PL, Jimenez-Ferrer I, Kenéz X, Björklund T, Nordström U, Brundin P, Swanberg M. Identification of Multiple QTLs Linked to Neuropathology in the Engrailed-1 Heterozygous Mouse Model of Parkinson's Disease. Scientific Reports. 6: 31701. PMID 27550741 DOI: 10.1038/srep31701  0.72
2016 Rey NL, Steiner JA, Maroof N, Luk KC, Madaj Z, Trojanowski JQ, Lee VM, Brundin P. Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson's disease. The Journal of Experimental Medicine. PMID 27503075 DOI: 10.1084/Jem.20160368  0.68
2016 Kurowska Z, Kordower JH, Stoessl AJ, Burke R, Brundin P, Yue Z, Brady ST, Milbrandt J, Trapp BD, Sherer TB, Medicetty S. Is Axonal Degeneration a Key Early Event in Parkinson's Disease? Journal of Parkinson's Disease. PMID 27497486 DOI: 10.3233/Jpd-160881  0.56
2016 Coetzee SG, Pierce S, Brundin P, Brundin L, Hazelett DJ, Coetzee GA. Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinson's disease etiology. Scientific Reports. 6: 30509. PMID 27461410 DOI: 10.1038/srep30509  1
2016 Brundin P, Ma J, Kordower JH. How strong is the evidence that Parkinson's disease is a prion disorder? Current Opinion in Neurology. PMID 27257944 DOI: 10.1097/Wco.0000000000000349  1
2016 Li W, Englund E, Widner H, Mattsson B, van Westen D, Lätt J, Rehncrona S, Brundin P, Björklund A, Lindvall O, Li JY. Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain. Proceedings of the National Academy of Sciences of the United States of America. PMID 27140603 DOI: 10.1073/Pnas.1605245113  0.92
2016 Barker RA, Parmar M, Kirkeby A, Björklund A, Thompson L, Brundin P. Are Stem Cell-Based Therapies for Parkinson's Disease Ready for the Clinic in 2016? Journal of Parkinson's Disease. PMID 27003785 DOI: 10.3233/Jpd-160798  1
2015 Tyson T, Steiner JA, Brundin P. Sorting Out Release, Uptake and Processing of Alpha-Synuclein During Prion-Like Spread of Pathology. Journal of Neurochemistry. PMID 26617280 DOI: 10.1111/jnc.13449  1
2015 George S, Brundin P. Immunotherapy in Parkinson's Disease: Micromanaging Alpha-Synuclein Aggregation. Journal of Parkinson's Disease. 5: 413-24. PMID 26406122 DOI: 10.3233/JPD-150630  1
2015 Dehay B, Vila M, Bezard E, Brundin P, Kordower JH. Alpha-synuclein propagation: New insights from animal models. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26347034 DOI: 10.1002/Mds.26370  1
2015 Brundin P, Wyse R. Parkinson disease: Laying the foundations for disease-modifying therapies in PD. Nature Reviews. Neurology. 11: 553-5. PMID 26303855 DOI: 10.1038/nrneurol.2015.150  1
2015 Brundin P, Atkin G, Lamberts JT. Basic science breaks through: New therapeutic advances in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1521-7. PMID 26177603 DOI: 10.1002/Mds.26332  1
2015 Roybon L, Mastracci TL, Li J, Stott SR, Leiter AB, Sussel L, Brundin P, Li JY. The Origin, Development and Molecular Diversity of Rodent Olfactory Bulb Glutamatergic Neurons Distinguished by Expression of Transcription Factor NeuroD1. Plos One. 10: e0128035. PMID 26030886 DOI: 10.1371/Journal.Pone.0128035  1
2015 Grey M, Dunning CJ, Gaspar R, Grey C, Brundin P, Sparr E, Linse S. Acceleration of α-synuclein aggregation by exosomes. The Journal of Biological Chemistry. 290: 2969-82. PMID 25425650 DOI: 10.1074/jbc.M114.585703  1
2015 Nordström U, Beauvais G, Ghosh A, Pulikkaparambil Sasidharan BC, Lundblad M, Fuchs J, Joshi RL, Lipton JW, Roholt A, Medicetty S, Feinstein TN, Steiner JA, Escobar Galvis ML, Prochiantz A, Brundin P. Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease. Neurobiology of Disease. 73: 70-82. PMID 25281317 DOI: 10.1016/J.Nbd.2014.09.012  1
2015 Lamberts JT, Hildebrandt EN, Brundin P. Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: a speculative synthesis. Neurobiology of Disease. 77: 276-83. PMID 25046996 DOI: 10.1016/J.Nbd.2014.07.002  1
2015 Reyes JF, Olsson TT, Lamberts JT, Devine MJ, Kunath T, Brundin P. A cell culture model for monitoring α-synuclein cell-to-cell transfer. Neurobiology of Disease. 77: 266-75. PMID 25046995 DOI: 10.1016/J.Nbd.2014.07.003  1
2014 Boza-Serrano A, Reyes JF, Rey NL, Leffler H, Bousset L, Nilsson U, Brundin P, Venero JL, Burguillos MA, Deierborg T. The role of Galectin-3 in α-synuclein-induced microglial activation. Acta Neuropathologica Communications. 2: 156. PMID 25387690 DOI: 10.1186/Preaccept-1285543917141325  1
2014 Janelidze S, Nordström U, Kügler S, Brundin P. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease. The Journal of Gene Medicine. 16: 300-8. PMID 25303717 DOI: 10.1002/Jgm.2779  1
2014 Bloem BR, Brundin P. How I examine my patient: the art of neurological examination for Parkinson's disease. Journal of Parkinson's Disease. 4: 563-5. PMID 25281608 DOI: 10.3233/JPD-149006  1
2014 Derkinderen P, Shannon KM, Brundin P. Gut feelings about smoking and coffee in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 976-9. PMID 24753353 DOI: 10.1002/mds.25882  1
2014 Simuni T, Brundin P. Is exenatide the next big thing in Parkinson's disease? Journal of Parkinson's Disease. 4: 345-7. PMID 24748153 DOI: 10.3233/JPD-149001  1
2014 George S, Rönnbäck A, Gouras GK, Petit GH, Grueninger F, Winblad B, Graff C, Brundin P. Lesion of the subiculum reduces the spread of amyloid beta pathology to interconnected brain regions in a mouse model of Alzheimer's disease. Acta Neuropathologica Communications. 2: 17. PMID 24517102 DOI: 10.1186/2051-5960-2-17  1
2014 Guloglu MO, Larsen A, Brundin P. Adipocytes derived from PA6 cells reliably promote the differentiation of dopaminergic neurons from human embryonic stem cells. Journal of Neuroscience Research. 92: 564-73. PMID 24482287 DOI: 10.1002/jnr.23355  1
2014 Reyes JF, Rey NL, Bousset L, Melki R, Brundin P, Angot E. Alpha-synuclein transfers from neurons to oligodendrocytes. Glia. 62: 387-98. PMID 24382629 DOI: 10.1002/Glia.22611  1
2014 Petit GH, Olsson TT, Brundin P. The future of cell therapies and brain repair: Parkinson's disease leads the way. Neuropathology and Applied Neurobiology. 40: 60-70. PMID 24372386 DOI: 10.1111/nan.12110  1
2014 Kefalopoulou Z, Politis M, Piccini P, Mencacci N, Bhatia K, Jahanshahi M, Widner H, Rehncrona S, Brundin P, Björklund A, Lindvall O, Limousin P, Quinn N, Foltynie T. Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports. Jama Neurology. 71: 83-7. PMID 24217017 DOI: 10.1001/Jamaneurol.2013.4749  1
2014 Kurowska Z, Brundin P, Schwab ME, Li JY. Intracellular Nogo-A facilitates initiation of neurite formation in mouse midbrain neurons in vitro. Neuroscience. 256: 456-66. PMID 24157929 DOI: 10.1016/J.Neuroscience.2013.10.029  1
2013 Zhang H, Petit GH, Gaughwin PM, Hansen C, Ranganathan S, Zuo X, Smith R, Roybon L, Brundin P, Mobley WC, Li JY. NGF rescues hippocampal cholinergic neuronal markers, restores neurogenesis, and improves the spatial working memory in a mouse model of Huntington's Disease. Journal of Huntington's Disease. 2: 69-82. PMID 25063430 DOI: 10.3233/Jhd-120026  1
2013 Looyenga BD, Brundin P. Silencing synuclein at the synapse with PLK2. Proceedings of the National Academy of Sciences of the United States of America. 110: 16293-4. PMID 24072649 DOI: 10.1073/pnas.1315622110  1
2013 George S, Petit GH, Gouras GK, Brundin P, Olsson R. Nonsteroidal selective androgen receptor modulators and selective estrogen receptor β agonists moderate cognitive deficits and amyloid-β levels in a mouse model of Alzheimer's disease. Acs Chemical Neuroscience. 4: 1537-48. PMID 24020966 DOI: 10.1021/Cn400133S  1
2013 Brundin P, Barker RA, Conn PJ, Dawson TM, Kieburtz K, Lees AJ, Schwarzschild MA, Tanner CM, Isaacs T, Duffen J, Matthews H, Wyse RK. Linked clinical trials--the development of new clinical learning studies in Parkinson's disease using screening of multiple prospective new treatments. Journal of Parkinson's Disease. 3: 231-9. PMID 24018336 DOI: 10.3233/Jpd-139000  1
2013 Rey NL, Petit GH, Bousset L, Melki R, Brundin P. Transfer of human α-synuclein from the olfactory bulb to interconnected brain regions in mice. Acta Neuropathologica. 126: 555-73. PMID 23925565 DOI: 10.1007/S00401-013-1160-3  1
2013 Hellstrand E, Grey M, Ainalem ML, Ankner J, Forsyth VT, Fragneto G, Haertlein M, Dauvergne MT, Nilsson H, Brundin P, Linse S, Nylander T, Sparr E. Adsorption of α-synuclein to supported lipid bilayers: positioning and role of electrostatics. Acs Chemical Neuroscience. 4: 1339-51. PMID 23823878 DOI: 10.1021/Cn400066T  1
2013 Barker RA, Stacy M, Brundin P. A new approach to disease-modifying drug trials in Parkinson's disease. The Journal of Clinical Investigation. 123: 2364-5. PMID 23728166 DOI: 10.1172/Jci69690  1
2013 Burguillos MA, Magnusson C, Nordin M, Lenshof A, Augustsson P, Hansson MJ, Elmér E, Lilja H, Brundin P, Laurell T, Deierborg T. Microchannel acoustophoresis does not impact survival or function of microglia, leukocytes or tumor cells. Plos One. 8: e64233. PMID 23724038 DOI: 10.1371/Journal.Pone.0064233  1
2013 Hansen C, Björklund T, Petit GH, Lundblad M, Murmu RP, Brundin P, Li JY. A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP. Neurobiology of Disease. 56: 145-55. PMID 23643841 DOI: 10.1016/J.Nbd.2013.04.017  1
2013 George S, Rey NL, Reichenbach N, Steiner JA, Brundin P. α-Synuclein: the long distance runner. Brain Pathology (Zurich, Switzerland). 23: 350-7. PMID 23587141 DOI: 10.1111/Bpa.12046  1
2013 Petit GH, Berkovich E, Hickery M, Kallunki P, Fog K, Fitzer-Attas C, Brundin P. Rasagiline ameliorates olfactory deficits in an alpha-synuclein mouse model of Parkinson's disease. Plos One. 8: e60691. PMID 23573275 DOI: 10.1371/Journal.Pone.0060691  1
2013 Grathwohl SA, Steiner JA, Britschgi M, Brundin P. Mind the gut: secretion of α-synuclein by enteric neurons. Journal of Neurochemistry. 125: 487-90. PMID 23448303 DOI: 10.1111/Jnc.12191  1
2013 Olanow CW, Brundin P. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder? Movement Disorders : Official Journal of the Movement Disorder Society. 28: 31-40. PMID 23390095 DOI: 10.1002/Mds.25373  1
2013 Dunning CJ, George S, Brundin P. What's to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease? Prion. 7: 92-7. PMID 23360753 DOI: 10.4161/pri.23806  1
2013 Rahman A, Ekman M, Shakirova Y, Andersson KE, Mörgelin M, Erjefält JS, Brundin P, Li JY, Swärd K. Late onset vascular dysfunction in the R6/1 model of Huntington's disease. European Journal of Pharmacology. 698: 345-53. PMID 23117088 DOI: 10.1016/J.Ejphar.2012.10.026  1
2013 Lema Tomé CM, Tyson T, Rey NL, Grathwohl S, Britschgi M, Brundin P. Inflammation and α-synuclein's prion-like behavior in Parkinson's disease--is there a link? Molecular Neurobiology. 47: 561-74. PMID 22544647 DOI: 10.1007/S12035-012-8267-8  1
2012 Brundin P, Langston JW. Journal of Parkinson's Disease--an excellent first year and a new sister. Journal of Parkinson's Disease. 2: 77. PMID 23933746 DOI: 10.3233/JPD-2012-12901  1
2012 Brundin P, Kordower JH. Neuropathology in transplants in Parkinson's disease: implications for disease pathogenesis and the future of cell therapy. Progress in Brain Research. 200: 221-41. PMID 23195421 DOI: 10.1016/B978-0-444-59575-1.00010-7  1
2012 Depboylu C, Höllerhage M, Schnurrbusch S, Brundin P, Oertel WH, Schrattenholz A, Höglinger GU. Neuregulin-1 receptor tyrosine kinase ErbB4 is upregulated in midbrain dopaminergic neurons in Parkinson disease. Neuroscience Letters. 531: 209-14. PMID 23123776 DOI: 10.1016/J.Neulet.2012.10.050  1
2012 Angot E, Steiner JA, Lema Tomé CM, Ekström P, Mattsson B, Björklund A, Brundin P. Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo. Plos One. 7: e39465. PMID 22737239 DOI: 10.1371/Journal.Pone.0039465  1
2012 Jeon I, Lee N, Li JY, Park IH, Park KS, Moon J, Shim SH, Choi C, Chang DJ, Kwon J, Oh SH, Shin DA, Kim HS, Do JT, Lee DR, ... ... Brundin P, et al. Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells. Stem Cells (Dayton, Ohio). 30: 2054-62. PMID 22628015 DOI: 10.1002/stem.1135  1
2012 Paul G, Özen I, Christophersen NS, Reinbothe T, Bengzon J, Visse E, Jansson K, Dannaeus K, Henriques-Oliveira C, Roybon L, Anisimov SV, Renström E, Svensson M, Haegerstrand A, Brundin P. The adult human brain harbors multipotent perivascular mesenchymal stem cells. Plos One. 7: e35577. PMID 22523602 DOI: 10.1371/Journal.Pone.0035577  1
2012 Dunning CJ, Reyes JF, Steiner JA, Brundin P. Can Parkinson's disease pathology be propagated from one neuron to another? Progress in Neurobiology. 97: 205-19. PMID 22115849 DOI: 10.1016/J.Pneurobio.2011.11.003  1
2012 Tyson T, Brundin P. VPS41-mediated neuroprotection in a Caenorhabditis elegans model of Parkinson's disease Future Neurology. 7: 255-258. DOI: 10.2217/Fnl.12.14  1
2012 Jeon I, Lee N, Li JY, Park IH, Park KS, Moon J, Shim SH, Choi C, Chang DJ, Kwon J, Oh SH, Shin DA, Kim HS, Do JT, Lee DR, ... ... Brundin P, et al. Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells (Stem Cells (2012) 30 (2054-2062)) Stem Cells. 30: 2602. DOI: 10.1002/Stem.1245  1
2011 Kurowska Z, Englund E, Widner H, Lindvall O, Li JY, Brundin P. Signs of degeneration in 12-22-year old grafts of mesencephalic dopamine neurons in patients with Parkinson's disease. Journal of Parkinson's Disease. 1: 83-92. PMID 23939259 DOI: 10.3233/Jpd-2011-11004  1
2011 Brundin P, Langston JW. Journal of Parkinson's disease. Journal of Parkinson's Disease. 1: 1. PMID 23934894 DOI: 10.3233/Jpd-2011-10022  1
2011 Grey M, Linse S, Nilsson H, Brundin P, Sparr E. Membrane interaction of α-synuclein in different aggregation states. Journal of Parkinson's Disease. 1: 359-71. PMID 23933657 DOI: 10.3233/Jpd-2011-11067  1
2011 Venero JL, Burguillos MA, Brundin P, Joseph B. The executioners sing a new song: killer caspases activate microglia. Cell Death and Differentiation. 18: 1679-91. PMID 21836616 DOI: 10.1038/Cdd.2011.107  1
2011 Duarte AI, Petit GH, Ranganathan S, Li JY, Oliveira CR, Brundin P, Björkqvist M, Rego AC. IGF-1 protects against diabetic features in an in vivo model of Huntington's disease. Experimental Neurology. 231: 314-9. PMID 21763311 DOI: 10.1016/J.Expneurol.2011.06.016  1
2011 Brundin P, Olsson R. Can α-synuclein be targeted in novel therapies for Parkinson's disease? Expert Review of Neurotherapeutics. 11: 917-9. PMID 21721907 DOI: 10.1586/Ern.11.73  1
2011 van der Burg JM, Winqvist A, Aziz NA, Maat-Schieman ML, Roos RA, Bates GP, Brundin P, Björkqvist M, Wierup N. Gastrointestinal dysfunction contributes to weight loss in Huntington's disease mice. Neurobiology of Disease. 44: 1-8. PMID 21624468 DOI: 10.1016/J.Nbd.2011.05.006  1
2011 Steiner JA, Angot E, Brundin P. A deadly spread: cellular mechanisms of α-synuclein transfer. Cell Death and Differentiation. 18: 1425-33. PMID 21566660 DOI: 10.1038/Cdd.2011.53  1
2011 Carlsson T, Schindler FR, Höllerhage M, Depboylu C, Arias-Carrión O, Schnurrbusch S, Rösler TW, Wozny W, Schwall GP, Groebe K, Oertel WH, Brundin P, Schrattenholz A, Höglinger GU. Systemic administration of neuregulin-1β1 protects dopaminergic neurons in a mouse model of Parkinson's disease. Journal of Neurochemistry. 117: 1066-74. PMID 21517849 DOI: 10.1111/J.1471-4159.2011.07284.X  1
2011 Gaughwin PM, Ciesla M, Lahiri N, Tabrizi SJ, Brundin P, Björkqvist M. Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease. Human Molecular Genetics. 20: 2225-37. PMID 21421997 DOI: 10.1093/Hmg/Ddr111  1
2011 Burguillos MA, Deierborg T, Kavanagh E, Persson A, Hajji N, Garcia-Quintanilla A, Cano J, Brundin P, Englund E, Venero JL, Joseph B. Caspase signalling controls microglia activation and neurotoxicity. Nature. 472: 319-24. PMID 21389984 DOI: 10.1038/nature09788  1
2011 Hansen C, Angot E, Bergström AL, Steiner JA, Pieri L, Paul G, Outeiro TF, Melki R, Kallunki P, Fog K, Li JY, Brundin P. α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. The Journal of Clinical Investigation. 121: 715-25. PMID 21245577 DOI: 10.1172/Jci43366  1
2011 Gaughwin P, Ciesla M, Yang H, Lim B, Brundin P. Stage-specific modulation of cortical neuronal development by Mmu-miR-134. Cerebral Cortex (New York, N.Y. : 1991). 21: 1857-69. PMID 21228099 DOI: 10.1093/Cercor/Bhq262  1
2011 Anisimov SV, Christophersen NS, Correia AS, Hall VJ, Sandelin I, Li JY, Brundin P. Identification of molecules derived from human fibroblast feeder cells that support the proliferation of human embryonic stem cells. Cellular & Molecular Biology Letters. 16: 79-88. PMID 21161417 DOI: 10.2478/S11658-010-0039-8  1
2011 van der Borght K, Köhnke R, Göransson N, Deierborg T, Brundin P, Erlanson-Albertsson C, Lindqvist A. Reduced neurogenesis in the rat hippocampus following high fructose consumption. Regulatory Peptides. 167: 26-30. PMID 21115071 DOI: 10.1016/J.Regpep.2010.11.002  1
2011 Fedele V, Roybon L, Nordström U, Li JY, Brundin P. Neurogenesis in the R6/2 mouse model of Huntington's disease is impaired at the level of NeuroD1. Neuroscience. 173: 76-81. PMID 20807561 DOI: 10.1016/J.Neuroscience.2010.08.022  1
2010 Morizane A, Darsalia V, Guloglu MO, Hjalt T, Carta M, Li JY, Brundin P. A simple method for large-scale generation of dopamine neurons from human embryonic stem cells. Journal of Neuroscience Research. 88: 3467-78. PMID 20981866 DOI: 10.1002/Jnr.22515  1
2010 Brundin P, Barker RA, Parmar M. Neural grafting in Parkinson's disease Problems and possibilities. Progress in Brain Research. 184: 265-94. PMID 20887880 DOI: 10.1016/S0079-6123(10)84014-2  1
2010 Deierborg T, Roybon L, Inacio AR, Pesic J, Brundin P. Brain injury activates microglia that induce neural stem cell proliferation ex vivo and promote differentiation of neurosphere-derived cells into neurons and oligodendrocytes. Neuroscience. 171: 1386-96. PMID 20883748 DOI: 10.1016/J.Neuroscience.2010.09.045  1
2010 Angot E, Steiner JA, Hansen C, Li JY, Brundin P. Are synucleinopathies prion-like disorders? The Lancet. Neurology. 9: 1128-38. PMID 20846907 DOI: 10.1016/S1474-4422(10)70213-1  1
2010 Carreira BP, Morte MI, Inácio A, Costa G, Rosmaninho-Salgado J, Agasse F, Carmo A, Couceiro P, Brundin P, Ambrósio AF, Carvalho CM, Araújo IM. Nitric oxide stimulates the proliferation of neural stem cells bypassing the epidermal growth factor receptor. Stem Cells (Dayton, Ohio). 28: 1219-30. PMID 20506358 DOI: 10.1002/Stem.444  1
2010 Allan LE, Petit GH, Brundin P. Cell transplantation in Parkinson's disease: problems and perspectives. Current Opinion in Neurology. 23: 426-32. PMID 20489615 DOI: 10.1097/Wco.0B013E32833B1F62  1
2010 Kuegler PB, Zimmer B, Waldmann T, Baudis B, Ilmjärv S, Hescheler J, Gaughwin P, Brundin P, Mundy W, Bal-Price AK, Schrattenholz A, Krause KH, van Thriel C, Rao MS, Kadereit S, et al. Markers of murine embryonic and neural stem cells, neurons and astrocytes: reference points for developmental neurotoxicity testing. Altex. 27: 17-42. PMID 20390237 DOI: 10.14573/Altex.2010.1.16  1
2010 Brundin P, Melki R, Kopito R. Prion-like transmission of protein aggregates in neurodegenerative diseases. Nature Reviews. Molecular Cell Biology. 11: 301-7. PMID 20308987 DOI: 10.1038/Nrm2873  1
2010 Li JY, Englund E, Widner H, Rehncrona S, Björklund A, Lindvall O, Brundin P. Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1091-6. PMID 20198645 DOI: 10.1002/Mds.23012  1
2010 Lee HS, Bae EJ, Yi SH, Shim JW, Jo AY, Kang JS, Yoon EH, Rhee YH, Park CH, Koh HC, Kim HJ, Choi HS, Han JW, Lee YS, Kim J, ... ... Brundin P, et al. Foxa2 and Nurr1 synergistically yield A9 nigral dopamine neurons exhibiting improved differentiation, function, and cell survival. Stem Cells (Dayton, Ohio). 28: 501-12. PMID 20049900 DOI: 10.1002/Stem.294  1
2010 Roybon L, Mastracci TL, Ribeiro D, Sussel L, Brundin P, Li JY. GABAergic differentiation induced by Mash1 is compromised by the bHLH proteins Neurogenin2, NeuroD1, and NeuroD2. Cerebral Cortex (New York, N.Y. : 1991). 20: 1234-44. PMID 19767311 DOI: 10.1093/Cercor/Bhp187  1
2010 Zhang H, Petit G, Gaughwin PM, Zuo X, Ranganathan S, Smith R, Roybon L, Brundin P, Mobley WC, Li J. B16 NGF improves the spatial working memory in R6/1 Huntington's disease transgenic mice through the augmentation of cholinergic function and neurogenesis Journal of Neurology, Neurosurgery & Psychiatry. 81: A16.4-A16. DOI: 10.1136/Jnnp.2010.222596.16  1
2010 Brundin P, Björklund A. Cell replacement therapy: Parkinson's disease Encyclopedia of Neuroscience. 649-653. DOI: 10.1016/B978-008045046-9.00003-6  1
2010 Augustsson P, Barnkob R, Grenvall C, Deierborg T, Brundin P, Bruus H, Laurell T. Measuring the acoustophoretic contrast factor of living cells in microchannels 14th International Conference On Miniaturized Systems For Chemistry and Life Sciences 2010, Microtas 2010. 2: 1337-1339.  1
2009 Angot E, Brundin P. Dissecting the potential molecular mechanisms underlying alpha-synuclein cell-to-cell transfer in Parkinson's disease. Parkinsonism & Related Disorders. 15: S143-7. PMID 20082977 DOI: 10.1016/S1353-8020(09)70802-8  1
2009 Kordower JH, Brundin P. Propagation of host disease to grafted neurons: accumulating evidence. Experimental Neurology. 220: 224-5. PMID 19786018 DOI: 10.1016/J.Expneurol.2009.09.016  1
2009 Maynard CJ, Böttcher C, Ortega Z, Smith R, Florea BI, Díaz-Hernández M, Brundin P, Overkleeft HS, Li JY, Lucas JJ, Dantuma NP. Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairment. Proceedings of the National Academy of Sciences of the United States of America. 106: 13986-91. PMID 19666572 DOI: 10.1073/Pnas.0906463106  1
2009 Smith R, Bacos K, Fedele V, Soulet D, Walz HA, Obermüller S, Lindqvist A, Björkqvist M, Klein P, Onnerfjord P, Brundin P, Mulder H, Li JY. Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion. Human Molecular Genetics. 18: 3942-54. PMID 19628478 DOI: 10.1093/Hmg/Ddp336  1
2009 van der Burg JM, Björkqvist M, Brundin P. Beyond the brain: widespread pathology in Huntington's disease. The Lancet. Neurology. 8: 765-74. PMID 19608102 DOI: 10.1016/S1474-4422(09)70178-4  1
2009 Khoshnan A, Ko J, Tescu S, Brundin P, Patterson PH. IKKalpha and IKKbeta regulation of DNA damage-induced cleavage of huntingtin. Plos One. 4: e5768. PMID 19488402 DOI: 10.1371/journal.pone.0005768  1
2009 Deierborg T, Staflin K, Pesic J, Roybon L, Brundin P, Lundberg C. Absence of striatal newborn neurons with mature phenotype following defined striatal and cortical excitotoxic brain injuries. Experimental Neurology. 219: 363-7. PMID 19427853 DOI: 10.1016/J.Expneurol.2009.05.002  1
2009 Lane EL, Vercammen L, Cenci MA, Brundin P. Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats. Experimental Neurology. 219: 355-8. PMID 19393238 DOI: 10.1016/J.Expneurol.2009.04.010  1
2009 Lane EL, Brundin P, Cenci MA. Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease. Neurobiology of Disease. 35: 42-51. PMID 19361557 DOI: 10.1016/J.Nbd.2009.03.014  1
2009 Roybon L, Hjalt T, Stott S, Guillemot F, Li JY, Brundin P. Neurogenin2 directs granule neuroblast production and amplification while NeuroD1 specifies neuronal fate during hippocampal neurogenesis. Plos One. 4: e4779. PMID 19274100 DOI: 10.1371/Journal.Pone.0004779  1
2009 Roybon L, Deierborg T, Brundin P, Li JY. Involvement of Ngn2, Tbr and NeuroD proteins during postnatal olfactory bulb neurogenesis. The European Journal of Neuroscience. 29: 232-43. PMID 19200230 DOI: 10.1111/J.1460-9568.2008.06595.X  1
2009 Kordower JH, Brundin P. Lewy body pathology in long-term fetal nigral transplants: is Parkinson's disease transmitted from one neural system to another? Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 254. PMID 19079079 DOI: 10.1038/Npp.2008.161  1
2009 Aziz NA, Van Der Burg JMM, Landwehrmeyer GB, Brundin P, Stijnen T, Roos RAC. Reply from the authors Neurology. 73: 572. DOI: 10.1212/WNL.0b013e3181af0cf4  1
2008 Fountaine TM, Venda LL, Warrick N, Christian HC, Brundin P, Channon KM, Wade-Martins R. The effect of alpha-synuclein knockdown on MPP+ toxicity in models of human neurons. The European Journal of Neuroscience. 28: 2459-73. PMID 19032594 DOI: 10.1111/J.1460-9568.2008.06527.X  1
2008 Correia AS, Anisimov SV, Li JY, Brundin P. Growth factors and feeder cells promote differentiation of human embryonic stem cells into dopaminergic neurons: a novel role for fibroblast growth factor-20. Frontiers in Neuroscience. 2: 26-34. PMID 18982104 DOI: 10.3389/Neuro.01.011.2008  1
2008 Aziz NA, van der Burg JM, Landwehrmeyer GB, Brundin P, Stijnen T, Roos RA. Weight loss in Huntington disease increases with higher CAG repeat number. Neurology. 71: 1506-13. PMID 18981372 DOI: 10.1212/01.wnl.0000334276.09729.0e  1
2008 Leist M, Bremer S, Brundin P, Hescheler J, Kirkeby A, Krause KH, Poerzgen P, Puceat M, Schmidt M, Schrattenholz A, Zak NB, Hentze H. The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy. Altex. 25: 163-90. PMID 18841314 DOI: 10.14573/Altex.2008.3.163  1
2008 Brundin P, Li JY, Holton JL, Lindvall O, Revesz T. Research in motion: the enigma of Parkinson's disease pathology spread. Nature Reviews. Neuroscience. 9: 741-5. PMID 18769444 DOI: 10.1038/Nrn2477  1
2008 Lane EL, Soulet D, Vercammen L, Cenci MA, Brundin P. Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease. Neurobiology of Disease. 32: 220-8. PMID 18675359 DOI: 10.1016/J.Nbd.2008.06.011  1
2008 Björkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R, Lahiri N, Raibon E, Lee RV, Benn CL, Soulet D, Magnusson A, Woodman B, Landles C, Pouladi MA, Hayden MR, ... ... Brundin P, et al. A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease. The Journal of Experimental Medicine. 205: 1869-77. PMID 18625748 DOI: 10.1084/Jem.20080178  1
2008 Deierborg T, Soulet D, Roybon L, Hall V, Brundin P. Emerging restorative treatments for Parkinson's disease. Progress in Neurobiology. 85: 407-32. PMID 18586376 DOI: 10.1016/J.Pneurobio.2008.05.001  1
2008 Wood NI, Goodman AO, van der Burg JM, Gazeau V, Brundin P, Björkqvist M, Petersén A, Tabrizi SJ, Barker RA, Morton AJ. Increased thirst and drinking in Huntington's disease and the R6/2 mouse. Brain Research Bulletin. 76: 70-9. PMID 18395613 DOI: 10.1016/J.Brainresbull.2007.12.007  1
2008 Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, Lashley T, Quinn NP, Rehncrona S, Björklund A, Widner H, Revesz T, Lindvall O, Brundin P. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nature Medicine. 14: 501-3. PMID 18391963 DOI: 10.1038/Nm1746  1
2008 Roybon L, Hjalt T, Christophersen NS, Li JY, Brundin P. Effects on differentiation of embryonic ventral midbrain progenitors by Lmx1a, Msx1, Ngn2, and Pitx3. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 3644-56. PMID 18385323 DOI: 10.1523/Jneurosci.0311-08.2008  1
2008 Bacos K, Björkqvist M, Petersén A, Luts L, Maat-Schieman ML, Roos RA, Sundler F, Brundin P, Mulder H, Wierup N. Islet beta-cell area and hormone expression are unaltered in Huntington's disease. Histochemistry and Cell Biology. 129: 623-9. PMID 18259770 DOI: 10.1007/S00418-008-0393-Z  1
2008 Li JY, Christophersen NS, Hall V, Soulet D, Brundin P. Critical issues of clinical human embryonic stem cell therapy for brain repair. Trends in Neurosciences. 31: 146-53. PMID 18255164 DOI: 10.1016/J.Tins.2007.12.001  1
2008 Araújo IM, Gil JM, Carreira BP, Mohapel P, Petersen A, Pinheiro PS, Soulet D, Bahr BA, Brundin P, Carvalho CM. Calpain activation is involved in early caspase-independent neurodegeneration in the hippocampus following status epilepticus. Journal of Neurochemistry. 105: 666-76. PMID 18088374 DOI: 10.1111/J.1471-4159.2007.05181.X  1
2008 Morizane A, Li JY, Brundin P. From bench to bed: the potential of stem cells for the treatment of Parkinson's disease. Cell and Tissue Research. 331: 323-36. PMID 18034267 DOI: 10.1007/S00441-007-0541-0  1
2008 Zuchner T, Brundin P. Mutant huntingtin can paradoxically protect neurons from death. Cell Death and Differentiation. 15: 435-42. PMID 17975550 DOI: 10.1038/Sj.Cdd.4402261  1
2008 van der Burg JM, Bacos K, Wood NI, Lindqvist A, Wierup N, Woodman B, Wamsteeker JI, Smith R, Deierborg T, Kuhar MJ, Bates GP, Mulder H, Erlanson-Albertsson C, Morton AJ, Brundin P, et al. Increased metabolism in the R6/2 mouse model of Huntington's disease. Neurobiology of Disease. 29: 41-51. PMID 17920283 DOI: 10.1016/J.Nbd.2007.07.029  1
2008 Björklund T, Morizane A, Kirik D, Brundin P. Future Cell-and Gene-Based Therapies for Parkinson's Disease Therapeutics of Parkinson's Disease and Other Movement Disorders. 145-156. DOI: 10.1002/9780470713990.ch8  1
2007 Correia AS, Anisimov SV, Roybon L, Li JY, Brundin P. Fibroblast growth factor-20 increases the yield of midbrain dopaminergic neurons derived from human embryonic stem cells. Frontiers in Neuroanatomy. 1: 4. PMID 18958198 DOI: 10.3389/Neuro.05.004.2007  1
2007 Hall VJ, Li JY, Brundin P. Restorative cell therapy for Parkinson's disease: a quest for the perfect cell. Seminars in Cell & Developmental Biology. 18: 859-69. PMID 17962052 DOI: 10.1016/J.Semcdb.2007.09.004  1
2007 Smith R, Klein P, Koc-Schmitz Y, Waldvogel HJ, Faull RL, Brundin P, Plomann M, Li JY. Loss of SNAP-25 and rabphilin 3a in sensory-motor cortex in Huntington's disease. Journal of Neurochemistry. 103: 115-23. PMID 17877635 DOI: 10.1111/J.1471-4159.2007.04703.X  1
2007 Björkqvist M, Leavitt BR, Nielsen JE, Landwehrmeyer B, Ecker D, Mulder H, Brundin P, Petersén A. Cocaine- and amphetamine-regulated transcript is increased in Huntington disease. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1952-4. PMID 17722045 DOI: 10.1002/Mds.21447  1
2007 Fahrenkrug J, Popovic N, Georg B, Brundin P, Hannibal J. Decreased VIP and VPAC2 receptor expression in the biological clock of the R6/2 Huntington's disease mouse. Journal of Molecular Neuroscience : Mn. 31: 139-48. PMID 17478887 DOI: 10.1385/Jmn/31:02:139  1
2007 Christophersen NS, Grønborg M, Petersen TN, Fjord-Larsen L, Jørgensen JR, Juliusson B, Blom N, Rosenblad C, Brundin P. Midbrain expression of Delta-like 1 homologue is regulated by GDNF and is associated with dopaminergic differentiation. Experimental Neurology. 204: 791-801. PMID 17320866 DOI: 10.1016/J.Expneurol.2007.01.014  1
2007 Christophersen NS, Brundin P. Large stem cell grafts could lead to erroneous interpretations of behavioral results? Nature Medicine. 13: 118; author reply 11. PMID 17290262 DOI: 10.1038/Nm0207-118A  1
2007 Anisimov SV, Christophersen NS, Correia AS, Li JY, Brundin P. "NeuroStem Chip": a novel highly specialized tool to study neural differentiation pathways in human stem cells. Bmc Genomics. 8: 46. PMID 17288595 DOI: 10.1186/1471-2164-8-46  1
2007 Paul G, Christophersen NS, Raymon H, Kiaer C, Smith R, Brundin P. Tyrosine hydroxylase expression is unstable in a human immortalized mesencephalic cell line--studies in vitro and after intracerebral grafting in vivo. Molecular and Cellular Neurosciences. 34: 390-9. PMID 17222562 DOI: 10.1016/J.Mcn.2006.11.010  1
2007 van der Borght K, Brundin P. Reduced expression of PSA-NCAM in the hippocampus and piriform cortex of the R6/1 and R6/2 mouse models of Huntington's disease. Experimental Neurology. 204: 473-8. PMID 17187781 DOI: 10.1016/J.Expneurol.2006.10.014  1
2007 Deierborg T, Li JY, Brundin P. Adult neurogenesis in neurodegenerative diseases Interaction Between Neurons and Glia in Aging and Disease. 445-460. DOI: 10.1007/978-0-387-70830-0_20  1
2006 Lindqvist A, Mohapel P, Bouter B, Frielingsdorf H, Pizzo D, Brundin P, Erlanson-Albertsson C. High-fat diet impairs hippocampal neurogenesis in male rats. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 13: 1385-8. PMID 17116226 DOI: 10.1111/J.1468-1331.2006.01500.X  1
2006 Christophersen NS, Meijer X, Jørgensen JR, Englund U, Grønborg M, Seiger A, Brundin P, Wahlberg LU. Induction of dopaminergic neurons from growth factor expanded neural stem/progenitor cell cultures derived from human first trimester forebrain. Brain Research Bulletin. 70: 457-66. PMID 17027782 DOI: 10.1016/J.Brainresbull.2006.07.001  1
2006 Nygren J, Wieloch T, Pesic J, Brundin P, Deierborg T. Enriched environment attenuates cell genesis in subventricular zone after focal ischemia in mice and decreases migration of newborn cells to the striatum. Stroke; a Journal of Cerebral Circulation. 37: 2824-9. PMID 17008628 DOI: 10.1161/01.Str.0000244769.39952.90  1
2006 Smith R, Chung H, Rundquist S, Maat-Schieman ML, Colgan L, Englund E, Liu YJ, Roos RA, Faull RL, Brundin P, Li JY. Cholinergic neuronal defect without cell loss in Huntington's disease. Human Molecular Genetics. 15: 3119-31. PMID 16987871 DOI: 10.1093/Hmg/Ddl252  1
2006 Westin JE, Lindgren HS, Gardi J, Nyengaard JR, Brundin P, Mohapel P, Cenci MA. Endothelial proliferation and increased blood-brain barrier permeability in the basal ganglia in a rat model of 3,4-dihydroxyphenyl-L-alanine-induced dyskinesia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 9448-61. PMID 16971529 DOI: 10.1523/Jneurosci.0944-06.2006  1
2006 Mohapel P, Mundt-Petersen K, Brundin P, Frielingsdorf H. Working memory training decreases hippocampal neurogenesis. Neuroscience. 142: 609-13. PMID 16962715 DOI: 10.1016/J.Neuroscience.2006.07.033  1
2006 Paul G, Ahn YH, Li JY, Brundin P. Transplantation in Parkinson's disease: The future looks bright. Advances in Experimental Medicine and Biology. 557: 221-48. PMID 16955713 DOI: 10.1007/0-387-30128-3_13  1
2006 Björkqvist M, Petersén A, Nielsen J, Ecker D, Mulder H, Hayden MR, Landwehrmeyer B, Brundin P, Leavitt BR. Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease. Clinical Genetics. 70: 78-9. PMID 16813610 DOI: 10.1111/J.1399-0004.2006.00636.X  1
2006 Brundin P, Angela Cenci M, Wieloch T. On the move to stimulate cell plasticity in the substantia nigra in Parkinson's disease. Experimental Neurology. 201: 1-6. PMID 16806183 DOI: 10.1016/J.Expneurol.2006.04.009  1
2006 Björkqvist M, Petersén A, Bacos K, Isaacs J, Norlén P, Gil J, Popovic N, Sundler F, Bates GP, Tabrizi SJ, Brundin P, Mulder H. Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease. Human Molecular Genetics. 15: 1713-21. PMID 16613897 DOI: 10.1093/Hmg/Ddl094  1
2006 Brederlau A, Correia AS, Anisimov SV, Elmi M, Paul G, Roybon L, Morizane A, Bergquist F, Riebe I, Nannmark U, Carta M, Hanse E, Takahashi J, Sasai Y, Funa K, ... Brundin P, et al. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells (Dayton, Ohio). 24: 1433-40. PMID 16556709 DOI: 10.1634/Stemcells.2005-0393  1
2006 Roybon L, Ma Z, Asztely F, Fosum A, Jacobsen SE, Brundin P, Li JY. Failure of transdifferentiation of adult hematopoietic stem cells into neurons. Stem Cells (Dayton, Ohio). 24: 1594-604. PMID 16556707 DOI: 10.1634/Stemcells.2005-0548  1
2006 Popovic N, Brundin P. Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases. International Journal of Pharmaceutics. 314: 120-6. PMID 16529886 DOI: 10.1016/J.Ijpharm.2005.09.040  1
2006 Lane EL, Winkler C, Brundin P, Cenci MA. The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat. Neurobiology of Disease. 22: 334-45. PMID 16406222 DOI: 10.1016/J.Nbd.2005.11.011  1
2006 Deierborg T, Soulet D, Brundin P. IV.4 Stem cells, viral vectors and other neurorestorative treatments Parkinsonism & Related Disorders. 12: 12. DOI: 10.1016/S1353-8020(07)70040-8  0.56
2006 Freeman TB, Brundin P. Important aspects of surgical methodology for transplantation in Parkinson's disease Restorative Therapies in Parkinson's Disease. 131-165. DOI: 10.1007/0-387-32823-2_8  1
2006 Brundin P, Olanow CW. Preface Restorative Therapies in Parkinson's Disease. vii-viii. DOI: 10.1007/0-387-32823-2  1
2005 Karlsson J, Petersén Å, Gidö G, Wieloch T, Brundin P. Combining Neuroprotective Treatment of Embryonic Nigral Donor Tissue with Mild Hypothermia of the Graft Recipient. Cell Transplantation. 14: 301-309. PMID 28866932 DOI: 10.3727/000000005783983089  1
2005 Li JY, Popovic N, Brundin P. The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 2: 447-64. PMID 16389308 DOI: 10.1602/Neurorx.2.3.447  1
2005 Puschban Z, Stefanova N, Petersén A, Winkler C, Brundin P, Poewe W, Wenning GK. Evidence for dopaminergic re-innervation by embryonic allografts in an optimized rat model of the Parkinsonian variant of multiple system atrophy. Brain Research Bulletin. 68: 54-8. PMID 16325004 DOI: 10.1016/J.Brainresbull.2005.08.025  1
2005 Correia AS, Anisimov SV, Li JY, Brundin P. Stem cell-based therapy for Parkinson's disease. Annals of Medicine. 37: 487-98. PMID 16278162 DOI: 10.1080/07853890500327967  1
2005 Roybon L, Brundin P, Li JY. Stromal cell-derived inducing activity does not promote dopaminergic differentiation, but enhances differentiation and proliferation of neural stem cell-derived astrocytes. Experimental Neurology. 196: 373-80. PMID 16199035 DOI: 10.1016/J.Expneurol.2005.08.023  1
2005 Papalexi E, Persson A, Björkqvist M, Petersén A, Woodman B, Bates GP, Sundler F, Mulder H, Brundin P, Popovic N. Reduction of GnRH and infertility in the R6/2 mouse model of Huntington's disease. The European Journal of Neuroscience. 22: 1541-6. PMID 16190907 DOI: 10.1111/J.1460-9568.2005.04324.X  1
2005 Karlsson J, Petersén A, Gidö G, Wieloch T, Brundin P. Combining neuroprotective treatment of embryonic nigral donor tissue with mild hypothermia of the graft recipient. Cell Transplantation. 14: 301-9. PMID 16052911 DOI: 10.3727/000000005783983089  1
2005 Lotharius J, Falsig J, van Beek J, Payne S, Dringen R, Brundin P, Leist M. Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 6329-42. PMID 16000623 DOI: 10.1523/Jneurosci.1746-05.2005  1
2005 Ahn YH, Bensadoun JC, Aebischer P, Zurn AD, Seiger A, Björklund A, Lindvall O, Wahlberg L, Brundin P, Kaminski Schierle GS. Increased fiber outgrowth from xeno-transplanted human embryonic dopaminergic neurons with co-implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor. Brain Research Bulletin. 66: 135-42. PMID 15982530 DOI: 10.1016/J.Brainresbull.2005.04.009  1
2005 Smith R, Brundin P, Li JY. Synaptic dysfunction in Huntington's disease: a new perspective. Cellular and Molecular Life Sciences : Cmls. 62: 1901-12. PMID 15968465 DOI: 10.1007/S00018-005-5084-5  1
2005 Smith R, Petersén A, Bates GP, Brundin P, Li JY. Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction. Neurobiology of Disease. 20: 673-84. PMID 15967669 DOI: 10.1016/J.Nbd.2005.05.008  1
2005 Gil JM, Mohapel P, Araújo IM, Popovic N, Li JY, Brundin P, Petersén A. Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice. Neurobiology of Disease. 20: 744-51. PMID 15951191 DOI: 10.1016/J.Nbd.2005.05.006  1
2005 Iancu R, Mohapel P, Brundin P, Paul G. Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice. Behavioural Brain Research. 162: 1-10. PMID 15922062 DOI: 10.1016/J.Bbr.2005.02.023  1
2005 Mohapel P, Frielingsdorf H, Häggblad J, Zachrisson O, Brundin P. Platelet-derived growth factor (PDGF-BB) and brain-derived neurotrophic factor (BDNF) induce striatal neurogenesis in adult rats with 6-hydroxydopamine lesions. Neuroscience. 132: 767-76. PMID 15837137 DOI: 10.1016/J.Neuroscience.2004.11.056  1
2005 Popovic N, Maingay M, Kirik D, Brundin P. Lentiviral gene delivery of GDNF into the striatum of R6/2 Huntington mice fails to attenuate behavioral and neuropathological changes. Experimental Neurology. 193: 65-74. PMID 15817265 DOI: 10.1016/J.Expneurol.2004.12.009  1
2005 Brundin LL, Brundin P. [Not everything worked perfectly in Thailand]. LäKartidningen. 102: 584; author reply 58. PMID 15786916  1
2005 Araújo IM, Xapelli S, Gil JM, Mohapel P, Petersén A, Pinheiro PS, Malva JO, Bahr BA, Brundin P, Carvalho CM. Proteolysis of NR2B by calpain in the hippocampus of epileptic rats. Neuroreport. 16: 393-6. PMID 15729144 DOI: 10.1097/00001756-200503150-00017  1
2005 Björkqvist M, Fex M, Renström E, Wierup N, Petersén A, Gil J, Bacos K, Popovic N, Li JY, Sundler F, Brundin P, Mulder H. The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient beta-cell mass and exocytosis. Human Molecular Genetics. 14: 565-74. PMID 15649949 DOI: 10.1093/Hmg/Ddi053  1
2005 Petersén A, Gil J, Maat-Schieman ML, Björkqvist M, Tanila H, Araújo IM, Smith R, Popovic N, Wierup N, Norlén P, Li JY, Roos RA, Sundler F, Mulder H, Brundin P. Orexin loss in Huntington's disease. Human Molecular Genetics. 14: 39-47. PMID 15525658 DOI: 10.1093/Hmg/Ddi004  1
2005 Paul G, Roybon L, Li J, Brundin P. Adult stem cell therapy – an option for the brain? Aktuelle Neurologie. 32. DOI: 10.1055/s-2005-916305  1
2004 Roybon L, Christophersen NS, Brundin P, Li JY. Stem cell therapy for Parkinson's disease: where do we stand? Cell and Tissue Research. 318: 261-73. PMID 15309619 DOI: 10.1007/S00441-004-0946-Y  1
2004 Frielingsdorf H, Schwarz K, Brundin P, Mohapel P. No evidence for new dopaminergic neurons in the adult mammalian substantia nigra. Proceedings of the National Academy of Sciences of the United States of America. 101: 10177-82. PMID 15210991 DOI: 10.1073/Pnas.0401229101  1
2004 Mohapel P, Brundin P. Harnessing endogenous stem cells to treat neurodegenerative disorders of the basal ganglia. Parkinsonism & Related Disorders. 10: 259-64. PMID 15196503 DOI: 10.1016/J.Parkreldis.2004.02.013  1
2004 Gil JM, Leist M, Popovic N, Brundin P, Petersén A. Asialoerythropoietin is not effective in the R6/2 line of Huntington's disease mice. Bmc Neuroscience. 5: 17. PMID 15134587 DOI: 10.1186/1471-2202-5-17  1
2003 Li JY, Plomann M, Brundin P. Huntington's disease: a synaptopathy? Trends in Molecular Medicine. 9: 414-20. PMID 14557053 DOI: 10.1016/J.Molmed.2003.08.006  1
2003 Ciechanover A, Brundin P. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron. 40: 427-46. PMID 14556719 DOI: 10.1016/S0896-6273(03)00606-8  1
2003 Maciel EN, Kaminski Schierle GS, Hansson O, Brundin P, Castilho RF. Cyclosporin A and Bcl-2 do not inhibit quinolinic acid-induced striatal excitotoxicity in rodents. Experimental Neurology. 183: 430-7. PMID 14552883 DOI: 10.1016/S0014-4886(03)00165-1  1
2003 EmgÃ¥rd M, Hallin U, Karlsson J, Bahr BA, Brundin P, Blomgren K. Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue: a role for protease activation. Journal of Neurochemistry. 86: 1223-32. PMID 12911630 DOI: 10.1046/J.1471-4159.2003.01931.X  1
2003 Björklund A, Dunnett SB, Brundin P, Stoessl AJ, Freed CR, Breeze RE, Levivier M, Peschanski M, Studer L, Barker R. Neural transplantation for the treatment of Parkinson's disease. The Lancet. Neurology. 2: 437-45. PMID 12849125 DOI: 10.1016/S1474-4422(03)00442-3  1
2003 Ahn YH, EmgÃ¥rd M, Brundin P. Ultrastructural characterization of dissociated embryonic ventral mesencephalic tissue treated with neuroprotectants. Cell Transplantation. 12: 235-41. PMID 12797378 DOI: 10.3727/000000003108746795  1
2003 Smith R, Lotharius J, Brundin P. [Free radicals and ailing proteins--the culprits behind Parkinson disease?]. LäKartidningen. 100: 1324-6, 1329-30. PMID 12739402  0.4
2003 Hansson O, Nylandsted J, Castilho RF, Leist M, Jäättelä M, Brundin P. Overexpression of heat shock protein 70 in R6/2 Huntington's disease mice has only modest effects on disease progression. Brain Research. 970: 47-57. PMID 12706247 DOI: 10.1016/S0006-8993(02)04275-0  1
2003 Li J, Brundin P. Grafting dopamine neurons in Parkinson's disease: do stem cells have a role in the future? Journal of Neurochemistry. 85: 13-13. DOI: 10.1046/J.1471-4159.85.S2.13_4.X  1
2003 Smith R, Lotharius J, Brundin P. Free radicals and ailing proteins - The culprits behind parkinson's disease | Fria radikaler och sjuka proteiner - Bovarna bakom parkinsons sjukdom? Lakartidningen. 100: 1324-1330.  1
2002 Love RM, Branton RL, Karlsson J, Brundin P, Clarke DJ. Effects of antioxidant pretreatment on the survival of embryonic dopaminergic neurons in vitro and following grafting in an animal model of Parkinson's disease. Cell Transplantation. 11: 653-62. PMID 12518892 DOI: 10.3727/000000002783985431  1
2002 Petersén A, Brundin P. Huntington's disease: the mystery unfolds? International Review of Neurobiology. 53: 315-39. PMID 12512345 DOI: 10.1016/S0074-7742(02)53012-9  1
2002 Lotharius J, Brundin P. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nature Reviews. Neuroscience. 3: 932-42. PMID 12461550 DOI: 10.1038/Nrn983  1
2002 Petersén A, Puschban Z, Lotharius J, NicNiocaill B, Wiekop P, O'Connor WT, Brundin P. Evidence for dysfunction of the nigrostriatal pathway in the R6/1 line of transgenic Huntington's disease mice. Neurobiology of Disease. 11: 134-46. PMID 12460553 DOI: 10.1006/Nbdi.2002.0534  1
2002 EmgÃ¥rd M, Blomgren K, Brundin P. Characterisation of cell damage and death in embryonic mesencephalic tissue: a study on ultrastructure, vital stains and protease activity. Neuroscience. 115: 1177-87. PMID 12453489 DOI: 10.1016/S0306-4522(02)00480-3  1
2002 Karlsson J, EmgÃ¥rd M, Brundin P. Comparison between survival of lazaroid-treated embryonic nigral neurons in cell suspensions, cultures and transplants. Brain Research. 955: 268-80. PMID 12419547 DOI: 10.1016/S0006-8993(02)03601-6  1
2002 Lotharius J, Brundin P. Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease. Human Molecular Genetics. 11: 2395-407. PMID 12351575 DOI: 10.1093/Hmg/11.20.2395  1
2002 Brundin P. GDNF treatment in Parkinson's disease: time for controlled clinical trials? Brain : a Journal of Neurology. 125: 2149-51. PMID 12244075 DOI: 10.1093/Brain/Awf217  1
2002 Lotharius J, Barg S, Wiekop P, Lundberg C, Raymon HK, Brundin P. Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. The Journal of Biological Chemistry. 277: 38884-94. PMID 12145295 DOI: 10.1074/jbc.M205518200  1
2002 Hagell P, Piccini P, Björklund A, Brundin P, Rehncrona S, Widner H, Crabb L, Pavese N, Oertel WH, Quinn N, Brooks DJ, Lindvall O. Dyskinesias following neural transplantation in Parkinson's disease. Nature Neuroscience. 5: 627-8. PMID 12042822 DOI: 10.1038/nn863  1
2002 Petersén A, Chase K, Puschban Z, DiFiglia M, Brundin P, Aronin N. Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease. Experimental Neurology. 175: 297-300. PMID 12009780 DOI: 10.1006/Exnr.2002.7885  1
2002 Zeron MM, Hansson O, Chen N, Wellington CL, Leavitt BR, Brundin P, Hayden MR, Raymond LA. Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron. 33: 849-60. PMID 11906693 DOI: 10.1016/S0896-6273(02)00615-3  1
2002 Paul G, Li JY, Brundin P. Stem cells: hype or hope? Drug Discovery Today. 7: 295-302. PMID 11854053 DOI: 10.1016/S1359-6446(01)02155-9  1
2002 Paul G, Brundin P. Funding embryonic stem-cell research: will commerce counteract collaboration? Drug Discovery Today. 7: 22-3. PMID 11790596 DOI: 10.1016/S1359-6446(01)02097-9  1
2001 Petersén A, Hansson O, Brundin P. [Huntington disease--yet another mad protein?]. LäKartidningen. 98: 5756-8, 5761. PMID 11789098  0.68
2001 Hansson O, Guatteo E, Mercuri NB, Bernardi G, Li XJ, Castilho RF, Brundin P. Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene. The European Journal of Neuroscience. 14: 1492-504. PMID 11722611 DOI: 10.1046/J.0953-816X.2001.01767.X  1
2001 Petersén A, Hansson O, Puschban Z, Sapp E, Romero N, Castilho RF, Sulzer D, Rice M, DiFiglia M, Przedborski S, Brundin P. Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine. The European Journal of Neuroscience. 14: 1425-35. PMID 11722604 DOI: 10.1046/J.0953-816X.2001.01765.X  1
2001 Petersén A A, Larsen KE, Behr GG, Romero N, Przedborski S, Brundin P, Sulzer D. Brain-derived neurotrophic factor inhibits apoptosis and dopamine-induced free radical production in striatal neurons but does not prevent cell death. Brain Research Bulletin. 56: 331-5. PMID 11719268 DOI: 10.1016/S0361-9230(01)00580-9  1
2001 Hansson O, Castilho RF, Korhonen L, Lindholm D, Bates GP, Brundin P. Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length. Journal of Neurochemistry. 78: 694-703. PMID 11520890 DOI: 10.1046/J.1471-4159.2001.00482.X  1
2001 Paul G, Brundin P. Is there a future for neural grafting? Drug Discovery Today. 6: 827-828. PMID 11495752 DOI: 10.1016/S1359-6446(01)01934-1  1
2001 Hagell P, Brundin P. Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease. Journal of Neuropathology and Experimental Neurology. 60: 741-52. PMID 11487048 DOI: 10.1093/Jnen/60.8.741  1
2001 Petersén A, Larsen KE, Behr GG, Romero N, Przedborski S, Brundin P, Sulzer D. Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration. Human Molecular Genetics. 10: 1243-54. PMID 11406606 DOI: 10.1093/Hmg/10.12.1243  1
2001 Brundin P, Dunnett S, Björklund A, Nikkhah G. Transplanted dopaminergic neurons: more or less? Nature Medicine. 7: 512-3. PMID 11329027 DOI: 10.1038/87796  1
2001 Nicniocaill B, Haraldsson B, Hansson O, O'Connor WT, Brundin P. Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6/1 Huntington transgenic mice. The European Journal of Neuroscience. 13: 206-10. PMID 11135020 DOI: 10.1046/J.0953-816X.2000.01379.X  1
2001 Brundin P, Hagell P. The neurobiology of cell transplantation in Parkinson's disease Clinical Neuroscience Research. 1: 507-520. DOI: 10.1016/S1566-2772(01)00028-7  1
2001 Petersén A, Hansson O, Brundin P. Huntington's disease - Yet another mad protein? | Huntingtons sjukdom - Ännu ett galet protein? Lakartidningen. 98: 5756-5761.  1
2000 Mundt-Petersen U, Karlsson J, Schierle GSK, Brundin P. Pretreatment with MK-801 or the Lazaroid U-83836E does not Enhance Striatal Graft Survival. Cell Transplantation. 9: 73-78. PMID 28876109 DOI: 10.1177/096368970000900110  1
2000 Brundin P, Karlsson J, Emgård M, Kaminski Schierle GS, Hansson O, Petersén Å, Castilho RF. Improving the Survival of Grafted Dopaminergic Neurons: A Review Over Current Approaches. Cell Transplantation. 9: 179-195. PMID 28153062  1
2000 Petersen A, Hansson O, EmgÃ¥rd M, Brundin P. Grafting of nigral tissue hibernated with tirilazad mesylate and glial cell line-derived neurotrophic factor. Cell Transplantation. 9: 577-84. PMID 11144955 DOI: 10.1177/096368970000900503  1
2000 Castilho RF, Hansson O, Brundin P. Improving the survival of grafted embryonic dopamine neurons in rodent models of Parkinson's disease. Progress in Brain Research. 127: 203-31. PMID 11142029 DOI: 10.1016/S0079-6123(00)27011-8  1
2000 Piccini P, Lindvall O, Björklund A, Brundin P, Hagell P, Ceravolo R, Oertel W, Quinn N, Samuel M, Rehncrona S, Widner H, Brooks DJ. Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Annals of Neurology. 48: 689-95. PMID 11079531 DOI: 10.1002/1531-8249(200011)48:5<689::Aid-Ana1>3.0.Co;2-N  1
2000 Mundt-Petersen U, Petersén A, EmgÃ¥rd M, Dunnett SB, Brundin P. Caspase inhibition increases embryonic striatal graft survival. Experimental Neurology. 164: 112-20. PMID 10877921 DOI: 10.1006/Exnr.2000.7407  1
2000 Hansson O, Castilho RF, Kaminski Schierle GS, Karlsson J, Nicotera P, Leist M, Brundin P. Additive effects of caspase inhibitor and lazaroid on the survival of transplanted rat and human embryonic dopamine neurons. Experimental Neurology. 164: 102-11. PMID 10877920 DOI: 10.1006/Exnr.2000.7406  1
2000 Castilho RF, Hansson O, Brundin P. FK506 and cyclosporin A enhance the survival of cultured and grafted rat embryonic dopamine neurons. Experimental Neurology. 164: 94-101. PMID 10877919 DOI: 10.1006/Exnr.2000.7405  1
2000 Brundin P, Pogarell O, Hagell P, Piccini P, Widner H, Schrag A, Kupsch A, Crabb L, Odin P, Gustavii B, Björklund A, Brooks DJ, Marsden CD, Oertel WH, Quinn NP, et al. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain : a Journal of Neurology. 123: 1380-90. PMID 10869050 DOI: 10.1093/Brain/123.7.1380  1
2000 Karlsson J, Emgard M, Brundin P, Burkitt MJ. trans-resveratrol protects embryonic mesencephalic cells from tert-butyl hydroperoxide: electron paramagnetic resonance spin trapping evidence for a radical scavenging mechanism. Journal of Neurochemistry. 75: 141-50. PMID 10854257 DOI: 10.1046/J.1471-4159.2000.0750141.X  1
2000 Karlsson J, EmgÃ¥rd M, Gidö G, Wieloch T, Brundin P. Increased survival of embryonic nigral neurons when grafted to hypothermic rats. Neuroreport. 11: 1665-8. PMID 10852221 DOI: 10.1097/00001756-200006050-00014  1
2000 Larsson LC, Czech KA, Brundin P, Widner H. Intrastriatal ventral mesencephalic xenografts of porcine tissue in rats: immune responses and functional effects. Cell Transplantation. 9: 261-72. PMID 10811398 DOI: 10.1177/096368970000900211  0.8
2000 Brundin P, Karlsson J, EmgÃ¥rd M, Schierle GS, Hansson O, Petersén A, Castilho RF. Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transplantation. 9: 179-95. PMID 10811392 DOI: 10.1177/096368970000900205  1
2000 Mundt-Petersen U, Karlsson J, Schierle GS, Brundin P. Pretreatment with MK-801 or the lazaroid U-83836E does not enhance striatal graft survival. Cell Transplantation. 9: 73-8. PMID 10784069 DOI: 10.1177/096368970000900110  1
2000 Petersén A, Castilho RF, Hansson O, Wieloch T, Brundin P. Oxidative stress, mitochondrial permeability transition and activation of caspases in calcium ionophore A23187-induced death of cultured striatal neurons. Brain Research. 857: 20-9. PMID 10700549 DOI: 10.1016/S0006-8993(99)02320-3  0.68
1999 EmgÃ¥rd M, Karlsson J, Hansson O, Brundin P. Patterns of cell death and dopaminergic neuron survival in intrastriatal nigral grafts. Experimental Neurology. 160: 279-88. PMID 10630212 DOI: 10.1006/Exnr.1999.7198  1
1999 Kaminski Schierle GS, Hansson O, Brundin P. Flunarizine improves the survival of grafted dopaminergic neurons. Neuroscience. 94: 17-20. PMID 10613492 DOI: 10.1016/S0306-4522(99)00324-3  0.68
1999 Kaminski Schierle GS, Hansson O, Ferrando-May E, Nicotera P, Brundin P, Leist M. Neuronal death in nigral grafts in the absence of poly (ADP-ribose) polymerase activation. Neuroreport. 10: 3347-51. PMID 10599843 DOI: 10.1097/00001756-199911080-00017  0.68
1999 Petersén A, EmgÃ¥rd M, Brundin P. Impact of a preceding striatal excitotoxic lesion and treatment with ciliary neurotrophic factor on striatal graft survival. Brain Research Bulletin. 50: 275-81. PMID 10582525 DOI: 10.1016/S0361-9230(99)00202-6  1
1999 Piccini P, Brooks DJ, Björklund A, Gunn RN, Grasby PM, Rimoldi O, Brundin P, Hagell P, Rehncrona S, Widner H, Lindvall O. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nature Neuroscience. 2: 1137-40. PMID 10570493 DOI: 10.1038/16060  1
1999 Schierle GS, Leist M, Martinou JC, Widner H, Nicotera P, Brundin P. Differential effects of Bcl-2 overexpression on fibre outgrowth and survival of embryonic dopaminergic neurons in intracerebral transplants. The European Journal of Neuroscience. 11: 3073-81. PMID 10510171 DOI: 10.1046/J.1460-9568.1999.00727.X  0.8
1999 Hansson O, Petersén A, Leist M, Nicotera P, Castilho RF, Brundin P. Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 96: 8727-32. PMID 10411943 DOI: 10.1073/Pnas.96.15.8727  0.68
1999 Schierle GS, Brundin P. Excitotoxicity plays a role in the death of tyrosine hydroxylase- immunopositive nigral neurons cultured in serum-free medium. Experimental Neurology. 157: 338-48. PMID 10364445 DOI: 10.1006/Exnr.1999.7066  0.72
1999 Hagell P, Schrag A, Piccini P, Jahanshahi M, Brown R, Rehncrona S, Widner H, Brundin P, Rothwell JC, Odin P, Wenning GK, Morrish P, Gustavii B, Björklund A, Brooks DJ, et al. Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain : a Journal of Neurology. 122: 1121-32. PMID 10356064 DOI: 10.1093/Brain/122.6.1121  1
1999 Grasbon T, Grasbon-Frodl EM, Juliusson B, Epstein C, Brundin P, Kampik A, Ehinger B. CuZn superoxide dismutase transgenic retinal transplants. Graefe's Archive For Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv FüR Klinische Und Experimentelle Ophthalmologie. 237: 336-41. PMID 10208267 DOI: 10.1007/S004170050241  1
1999 Brundin P, Petersén A, Hansson O. Graft survival. Journal of Neurosurgery. 90: 804-6. PMID 10193633 DOI: 10.3171/jns.1999.90.4.0804a  1
1999 Karlsson J, Love RM, Clarke DJ, Brundin P. Effects of anaesthetics and lazaroid U-83836E on survival of transplanted rat dopaminergic neurones. Brain Research. 821: 546-50. PMID 10064845 DOI: 10.1016/S0006-8993(99)01176-2  1
1999 Schierle GS, Hansson O, Leist M, Nicotera P, Widner H, Brundin P. Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nature Medicine. 5: 97-100. PMID 9883846 DOI: 10.1038/4785  0.8
1998 Nakao N, Brundin P. Neurodegeneration and glutamate induced oxidative stress. Progress in Brain Research. 116: 245-63. PMID 9932381 DOI: 10.1016/S0079-6123(08)60441-0  1
1998 Duan WM, Widner H, Cameron RM, Brundin P. Quinolinic acid-induced inflammation in the striatum does not impair the survival of neural allografts in the rat. The European Journal of Neuroscience. 10: 2595-606. PMID 9767390 DOI: 10.1046/J.1460-9568.1998.00279.X  1
1998 Karlsson J, Emgârd M, Rosenblad C, Brundin P. Treatment with the spin-trap agent alpha-phenyl-N-tert-butyl nitrone does not enhance the survival of embryonic or adult dopamine neurons. Brain Research. 805: 155-68. PMID 9733957 DOI: 10.1016/S0006-8993(98)00702-1  1
1998 Schierle GS, Karlsson J, Brundin P. MK-801 does not enhance dopaminergic cell survival in embryonic nigral grafts. Neuroreport. 9: 1313-6. PMID 9631420 DOI: 10.1097/00001756-199805110-00011  1
1997 Duan WM, Brundin P, Widner H. Addition of allogeneic spleen cells causes rejection of intrastriatal embryonic mesencephalic allografts in the rat. Neuroscience. 77: 599-609. PMID 9472415 DOI: 10.1016/S0306-4522(96)00470-8  0.8
1997 Duan WM, Cameron RM, Brundin P, Widner H. Rat intrastriatal neural allografts challenged with skin allografts at different time points. Experimental Neurology. 148: 334-47. PMID 9398476 DOI: 10.1006/Exnr.1997.6656  0.8
1997 Othberg A, Keep M, Brundin P, Lindvall O. Tirilazad mesylate improves survival of rat and human embryonic mesencephalic neurons in vitro. Experimental Neurology. 147: 498-502. PMID 9344573 DOI: 10.1006/Exnr.1997.6594  1
1997 Wenning GK, Odin P, Morrish P, Rehncrona S, Widner H, Brundin P, Rothwell JC, Brown R, Gustavii B, Hagell P, Jahanshahi M, Sawle G, Björklund A, Brooks DJ, Marsden CD, et al. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Annals of Neurology. 42: 95-107. PMID 9225690 DOI: 10.1002/Ana.410420115  1
1997 Grasbon-Frodl EM, Nakao N, Lindvall O, Brundin P. Developmental features of human striatal tissue transplanted in a rat model of Huntington's disease. Neurobiology of Disease. 3: 299-311. PMID 9173927 DOI: 10.1006/Nbdi.1996.0124  1
1997 EmgÃ¥rd-Mattson M, Karlsson J, Nakao N, Brundin P. Addition of lateral ganglionic eminence to rat mesencephalic grafts affects fiber outgrowth but does not enhance function. Cell Transplantation. 6: 277-86. PMID 9171160 DOI: 10.1016/S0963-6897(97)00038-9  1
1997 Barkats M, Nakao N, Grasbon-Frodl EM, Bilang-Bleuel A, Revah F, Mallet J, Brundin P. Intrastriatal grafts of embryonic mesencephalic rat neurons genetically modified using an adenovirus encoding human Cu/Zn superoxide dismutase. Neuroscience. 78: 703-13. PMID 9153652 DOI: 10.1016/S0306-4522(96)00526-X  1
1997 Nakao N, Brundin P. Effects of alpha-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid. Neuroscience. 76: 749-61. PMID 9135048 DOI: 10.1016/S0306-4522(96)00223-0  1
1996 Grasbon-Frodl EM, Nakao N, Brundin P. The lazaroid U-83836E improves the survival of rat embryonic mesencephalic tissue stored at 4 degrees C and subsequently used for cultures or intracerebral transplantation. Brain Research Bulletin. 39: 341-7. PMID 9138743 DOI: 10.1016/0361-9230(96)00001-9  1
1996 Nakao N, Grasbon-Frodl EM, Widner H, Brundin P. DARPP-32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw reaching in an animal model of Huntington's disease. Neuroscience. 74: 959-70. PMID 8895865 DOI: 10.1016/0306-4522(96)00238-2  1
1996 Brundin P, Fricker RA, Nakao N. Paucity of P-zones in striatal grafts prohibit commencement of clinical trials in Huntington's disease. Neuroscience. 71: 895-97. PMID 8867057 DOI: 10.1016/0306-4522(95)00162-X  1
1996 Duan WM, Brundin P, Grasbon-Frodl EM, Widner H. Methylprednisolone prevents rejection of intrastriatal grafts of xenogeneic embryonic neural tissue in adult rats. Brain Research. 712: 199-212. PMID 8814894 DOI: 10.1016/0006-8993(95)01409-8  0.8
1996 Nakao N, Grasbon-Frodl EM, Widner H, Brundin P. Antioxidant treatment protects striatal neurons against excitotoxic insults. Neuroscience. 73: 185-200. PMID 8783241 DOI: 10.1016/0306-4522(96)00034-6  1
1996 Grasbon-Frodl EM, Nakao N, Lindvall O, Brundin P. Phenotypic development of the human embryonic striatal primordium: a study of cultured and grafted neurons from the lateral and medial ganglionic eminences. Neuroscience. 73: 171-83. PMID 8783240 DOI: 10.1016/0306-4522(96)00008-5  1
1996 Nakao N, Odin P, Lindvall O, Brundin P. Differential trophic effects of basic fibroblast growth factor, insulin-like growth factor-1, and neurotrophin-3 on striatal neurons in culture. Experimental Neurology. 138: 144-57. PMID 8593889 DOI: 10.1006/Exnr.1996.0053  1
1995 Nakao N, Brundin P, Funa K, Lindvall O, Odin P. Trophic and protective actions of brain-derived neurotrophic factor on striatal DARPP-32-containing neurons in vitro. Brain Research. Developmental Brain Research. 90: 92-101. PMID 8719332 DOI: 10.1016/0165-3806(96)83489-4  1
1995 Duan WM, Widner H, Frodl EM, Brundin P. Immune reactions following systemic immunization prior or subsequent to intrastriatal transplantation of allogeneic mesencephalic tissue in adult rats. Neuroscience. 64: 629-41. PMID 7715776 DOI: 10.1016/0306-4522(94)00416-3  0.8
1995 Duan WM, Widner H, Brundin P. Temporal pattern of host responses against intrastriatal grafts of syngeneic, allogeneic or xenogeneic embryonic neuronal tissue in rats. Experimental Brain Research. 104: 227-42. PMID 7672016 DOI: 10.1007/Bf00242009  0.8
1995 Nakao N, Frodl EM, Widner H, Carlson E, Eggerding FA, Epstein CJ, Brundin P. Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease. Nature Medicine. 1: 226-31. PMID 7585038 DOI: 10.1038/Nm0395-226  1
1994 Nakao N, Odin P, Brundin P. Selective sub-dissection of the striatal primordium for cultures affects the yield of DARPP-32-containing neurones. Neuroreport. 5: 1081-4. PMID 8080963 DOI: 10.1097/00001756-199405000-00015  1
1994 Frodl EM, Nakao N, Brundin P. Lazaroids improve the survival of cultured rat embryonic mesencephalic neurones. Neuroreport. 5: 2393-6. PMID 7881066 DOI: 10.1097/00001756-199411000-00045  1
1994 Nakao N, Brundin P, Funa K, Lindvall O, Odin P. Platelet-derived growth factor exerts trophic effects on rat striatal DARPP-32-containing neurons in culture. Experimental Brain Research. 101: 291-6. PMID 7843315 DOI: 10.1007/BF00228749  1
1994 Nakao N, Frodl EM, Duan WM, Widner H, Brundin P. Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proceedings of the National Academy of Sciences of the United States of America. 91: 12408-12. PMID 7809050 DOI: 10.1073/Pnas.91.26.12408  1
1993 Sauer H, Fischer W, Nikkhah G, Wiegand SJ, Brundin P, Lindsay RM, Björklund A. Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts. Brain Research. 626: 37-44. PMID 8281451 DOI: 10.1016/0006-8993(93)90560-A  1
1993 Widner H, Brundin P. Sequential intracerebral transplantation of allogeneic and syngeneic fetal dopamine-rich neuronal tissue in adult rats: will the first graft be rejected? Cell Transplantation. 2: 307-17. PMID 8162272 DOI: 10.1177/096368979300200413  0.8
1993 Nikkhah G, Odin P, Smits A, Tingström A, Othberg A, Brundin P, Funa K, Lindvall O. Platelet-derived growth factor promotes survival of rat and human mesencephalic dopaminergic neurons in culture. Experimental Brain Research. 92: 516-23. PMID 8095907 DOI: 10.1007/BF00229041  1
1993 Brundin P, Wictorin K. Neuronal transplantation in rat models of Parkinson's and Huntington's diseases Seminars in Neuroscience. 5: 413-421. DOI: 10.1016/S1044-5765(05)80013-2  1
1992 Wictorin K, Brundin P, Sauer H, Lindvall O, Björklund A. Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats. The Journal of Comparative Neurology. 323: 475-94. PMID 1358925 DOI: 10.1002/Cne.903230403  1
1991 Bengzon J, Brundin P, Kalén P, Kokaia M, Lindvall O. Host regulation of noradrenaline release from grafts of seizure-suppressant locus coeruleus neurons. Experimental Neurology. 111: 49-54. PMID 1984432 DOI: 10.1016/0014-4886(91)90049-I  1
1991 Horellou P, Lundberg C, Le Bourdellès B, Wictorin K, Brundin P, Kalén P, Björklund A, Mallet J. Behavioural effects of genetically engineered cells releasing dopa and dopamine after intracerebral grafting in a rat model of Parkinson's disease. Journal De Physiologie. 85: 158-70. PMID 1687823  1
1990 Aramant R, Seiler M, Ehinger B, Bergström A, Gustavii B, Brundin P, Adolph AR. Transplantation of human embryonic retina to adult rat retina. Restorative Neurology and Neuroscience. 2: 9-22. PMID 21551868 DOI: 10.3233/Rnn-1990-2102  1
1990 Mandel RJ, Brundin P, Björklund A. The Importance of Graft Placement and Task Complexity for Transplant-Induced Recovery of Simple and Complex Sensorimotor Deficits in Dopamine Denervated Rats. The European Journal of Neuroscience. 2: 888-894. PMID 12106096 DOI: 10.1111/J.1460-9568.1990.Tb00400.X  1
1990 Doucet G, Brundin P, Descarries L, Björklund A. Effect of Prior Dopamine Denervation on Survival and Fiber Outgrowth from Intrastriatal Fetal Mesencephalic Grafts. The European Journal of Neuroscience. 2: 279-290. PMID 12106034 DOI: 10.1111/j.1460-9568.1990.tb00419.x  1
1990 Nilsson OG, Brundin P, Björklund A. Amelioration of spatial memory impairment by intrahippocampal grafts of mixed septal and raphe tissue in rats with combined cholinergic and serotonergic denervation of the forebrain. Brain Research. 515: 193-206. PMID 2357557 DOI: 10.1016/0006-8993(90)90596-4  1
1990 Clarke DJ, Nilsson OG, Brundin P, Björklund A. Synaptic connections formed by grafts of different types of cholinergic neurons in the host hippocampus. Experimental Neurology. 107: 11-22. PMID 2295316 DOI: 10.1016/0014-4886(90)90059-2  1
1990 Lindvall O, Rehncrona S, Brundin P, Gustavii B, Astedt B, Widner H, Lindholm T, Björklund A, Leenders KL, Rothwell JC. Neural transplantation in Parkinson's disease: the Swedish experience. Progress in Brain Research. 82: 729-34. PMID 2290977 DOI: 10.1016/S0079-6123(08)62666-7  1
1990 Brundin P, Odin P, Widner H. [Promising new results with transplantation of nerve cells to the brain in Parkinson disease]. LäKartidningen. 87: 3761-3. PMID 2233056  0.8
1990 Horellou P, Brundin P, Kalén P, Mallet J, Björklund A. In vivo release of dopa and dopamine from genetically engineered cells grafted to the denervated rat striatum. Neuron. 5: 393-402. PMID 2119630 DOI: 10.1016/0896-6273(90)90078-T  1
1990 Triarhou LC, Brundin P, Doucet G, Norton J, Björklund A, Ghetti B. Intrastriatal implants of mesencephalic cell suspensions in weaver mutant mice: ultrastructural relationships of dopaminergic dendrites and axons issued from the graft. Experimental Brain Research. 79: 3-17. PMID 1968850 DOI: 10.1007/BF00228869  1
1990 Wictorin K, Clarke DJ, Bolam JP, Brundin P, Gustavii B, Lindvall O, Björklund A. Extensive efferent projections of intra-striatally transplanted striatal neurons as revealed by a species-specific neurofilament marker and anterograde axonal tracing. Progress in Brain Research. 82: 391-9. PMID 1705355 DOI: 10.1016/S0079-6123(08)62627-8  1
1990 Wictorin K, Brundin P, Gustavii B, Lindvall O, Björklund A. Reformation of long axon pathways in adult rat central nervous system by human forebrain neuroblasts. Nature. 347: 556-8. PMID 1699131 DOI: 10.1038/347556A0  1
1989 Lindvall O, Rehncrona S, Brundin P, Gustavii B, Astedt B, Widner H, Lindholm T, Björklund A, Leenders KL, Rothwell JC, Frackowiak R, Marsden D, Johnels B, Steg G, Freedman R, et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Archives of Neurology. 46: 615-31. PMID 2786405 DOI: 10.1001/Archneur.1989.00520420033021  1
1989 Doucet G, Brundin P, Seth S, Murata Y, Strecker RE, Triarhou LC, Ghetti B, Björklund A. Degeneration and graft-induced restoration of dopamine innervation in the weaver mouse neostriatum: a quantitative radioautographic study of [3H]dopamine uptake. Experimental Brain Research. 77: 552-68. PMID 2572446 DOI: 10.1007/Bf00249608  1
1989 Forni C, Brundin P, Strecker RE, el Ganouni S, Björklund A, Nieoullon A. Time-course of recovery of dopamine neuron activity during reinnervation of the denervated striatum by fetal mesencephalic grafts as assessed by in vivo voltammetry. Experimental Brain Research. 76: 75-87. PMID 2502425 DOI: 10.1007/Bf00253625  1
1989 Brundin P, Widner H, Nilsson OG, Strecker RE, Björklund A. Intracerebral xenografts of dopamine neurons: the role of immunosuppression and the blood-brain barrier. Experimental Brain Research. 75: 195-207. PMID 2495977 DOI: 10.1007/Bf00248542  1
1989 Doucet G, Murata Y, Brundin P, Bosler O, Mons N, Geffard M, Ouimet CC, Björklund A. Host afferents into intrastriatal transplants of fetal ventral mesencephalon. Experimental Neurology. 106: 1-19. PMID 2477271 DOI: 10.1016/0014-4886(89)90139-8  1
1989 Daszuta A, Kalén P, Strecker RE, Brundin P, Björklund A. Serotonin neurons grafted to the adult rat hippocampus. II. 5-HT release as studied by intracerebral microdialysis. Brain Research. 498: 323-32. PMID 2477113 DOI: 10.1016/0006-8993(89)91111-6  1
1988 Nilsson OG, Brundin P, Widner H, Strecker RE, Björklund A. Human fetal basal forebrain neurons grafted to the denervated rat hippocampus produce an organotypic cholinergic reinnervation pattern. Brain Research. 456: 193-8. PMID 3409035 DOI: 10.1016/0006-8993(88)90363-0  1
1988 Brundin P, Strecker RE, Widner H, Clarke DJ, Nilsson OG, Astedt B, Lindvall O, Björklund A. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Experimental Brain Research. 70: 192-208. PMID 3402564 DOI: 10.1007/Bf00271860  1
1988 Brundin P, Barbin G, Strecker RE, Isacson O, Prochiantz A, Björklund A. Survival and function of dissociated rat dopamine neurones grafted at different developmental stages or after being cultured in vitro. Brain Research. 467: 233-43. PMID 3378172 DOI: 10.1016/0165-3806(88)90027-2  1
1988 Nilsson OG, Clarke DJ, Brundin P, Björklund A. Comparison of growth and reinnervation properties of cholinergic neurons from different brain regions grafted to the hippocampus. The Journal of Comparative Neurology. 268: 204-22. PMID 3360985 DOI: 10.1002/Cne.902680206  1
1988 Gage FH, Brundin P, Strecker R, Dunnett SB, Isacson O, Bjorklund A. Intracerebral neuronal grafting in experimental animal models of age-related motor dysfunction. Annals of the New York Academy of Sciences. 515: 383-94. PMID 3284426 DOI: 10.1111/J.1749-6632.1988.Tb33014.X  1
1988 Clarke DJ, Brundin P, Strecker RE, Nilsson OG, Björklund A, Lindvall O. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: ultrastructural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry. Experimental Brain Research. 73: 115-26. PMID 3145209 DOI: 10.1007/Bf00279666  1
1988 Brundin P, Strecker RE, Clarke DJ, Widner H, Nilsson OG, Astedt B, Lindvall O, Björklund A. Can human fetal dopamine neuron grafts provide a therapy for Parkinson's disease? Progress in Brain Research. 78: 441-8. PMID 3073425 DOI: 10.1016/S0079-6123(08)60316-7  1
1988 Widner H, Brundin P. Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis. Brain Research. 472: 287-324. PMID 3066438 DOI: 10.1016/0165-0173(88)90010-0  0.8
1988 Brundin P, Strecker RE, Gage FH, Lindvall O, Björklund A. Intracerebral transplantation of dopamine neurons: understanding the functional role of the mesolimbocortical dopamine system and developing a therapy for Parkinson's disease. Annals of the New York Academy of Sciences. 537: 148-60. PMID 3059921 DOI: 10.1111/J.1749-6632.1988.Tb42103.X  1
1988 Daszuta A, Strecker RE, Brundin P, Björklund A. Serotonin neurons grafted to the adult rat hippocampus. I. Time course of growth as studied by immunohistochemistry and biochemistry. Brain Research. 458: 1-19. PMID 2463040 DOI: 10.1016/0006-8993(88)90490-8  1
1987 Brundin P, Björklund A. Survival, growth and function of dopaminergic neurons grafted to the brain. Progress in Brain Research. 71: 293-308. PMID 3588950 DOI: 10.1016/S0079-6123(08)61832-4  0.92
1987 Isacson O, Pritzel M, Dawbarn D, Brundin P, Kelly PA, Wiklund L, Emson PC, Gage FH, Dunnett SB, Björklund A. Striatal neural transplants in the ibotenic acid-lesioned rat neostriatum. Cellular and functional aspects. Annals of the New York Academy of Sciences. 495: 537-55. PMID 3474959 DOI: 10.1111/j.1749-6632.1987.tb23699.x  1
1987 Brundin P, Strecker RE, Lindvall O, Isacson O, Nilsson OG, Barbin G, Prochiantz A, Forni C, Nieoullon A, Widner H. Intracerebral grafting of dopamine neurons. Experimental basis for clinical trials in patients with Parkinson's disease. Annals of the New York Academy of Sciences. 495: 473-96. PMID 3474955 DOI: 10.1111/J.1749-6632.1987.Tb23695.X  1
1987 Brundin P, Strecker RE, Londos E, Björklund A. Dopamine neurons grafted unilaterally to the nucleus accumbens affect drug-induced circling and locomotion. Experimental Brain Research. 69: 183-94. PMID 3125059 DOI: 10.1007/Bf00247041  1
1987 Isacson O, Dawbarn D, Brundin P, Gage FH, Emson PC, Björklund A. Neural grafting in a rat model of Huntington's disease: striosomal-like organization of striatal grafts as revealed by acetylcholinesterase histochemistry, immunocytochemistry and receptor autoradiography. Neuroscience. 22: 481-97. PMID 2823174 DOI: 10.1016/0306-4522(87)90348-4  1
1987 Strecker RE, Sharp T, Brundin P, Zetterström T, Ungerstedt U, Björklund A. Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis. Neuroscience. 22: 169-78. PMID 2819773 DOI: 10.1016/0306-4522(87)90207-7  1
1987 POULSEN E, BRUNDIN P, STRECKER RE, BJÖRKLUND A. Fetal Dopamine Neurons Implanted Unilaterally into the Nucleus Accumbens Drive Amphetamine-induced Locomotion and Circling Annals of the New York Academy of Sciences. 495: 774-776. DOI: 10.1111/j.1749-6632.1987.tb23736.x  0.92
1987 Björklund A, Lindvall O, Isacson O, Brundin P, Wictorin K, Strecker RE, Clarke DJ, Dunnett SB. Mechanisms of action of intracerebral neural implants: studies on nigral and striatal grafts to the lesioned striatum Trends in Neurosciences. 10: 509-516. DOI: 10.1016/0166-2236(87)90131-7  1
1986 Brundin P, Nilsson OG, Strecker RE, Lindvall O, Astedt B, Björklund A. Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Experimental Brain Research. 65: 235-40. PMID 3542544 DOI: 10.1007/Bf00243848  1
1986 Brundin P, Isacson O, Gage FH, Prochiantz A, Björklund A. The rotating 6-hydroxydopamine-lesioned mouse as a model for assessing functional effects of neuronal grafting. Brain Research. 366: 346-9. PMID 3084035 DOI: 10.1016/0006-8993(86)91316-8  0.92
1986 Brundin P, Isacson O, Gage FH, Björklund A. Intrastriatal grafting of dopamine-containing neuronal cell suspensions: effects of mixing with target or non-target cells. Brain Research. 389: 77-84. PMID 3081240 DOI: 10.1016/0165-3806(86)90174-4  0.92
1985 Gage FH, Brundin P, Isacson O, Björklund A. Rat fetal brain tissue grafts survive and innervate host brain following five day pregraft tissue storage. Neuroscience Letters. 60: 133-7. PMID 4058805 DOI: 10.1016/0304-3940(85)90233-2  0.92
1985 Brundin P, Barbin G, Isacson O, Mallat M, Chamak B, Prochiantz A, Gage FH, Björklund A. Survival of intracerebrally grafted rat dopamine neurons previously cultured in vitro. Neuroscience Letters. 61: 79-84. PMID 3935983 DOI: 10.1016/0304-3940(85)90404-5  0.92
1985 Brundin P, Nilsson OG, Gage FH, Björklund A. Cyclosporin A increases survival of cross-species intrastriatal grafts of embryonic dopamine-containing neurons. Experimental Brain Research. 60: 204-8. PMID 3930278 DOI: 10.1007/BF00237035  1
1985 Emson PC, Dawbarn D, Rossor MN, Rehfeld JF, Brundin P, Isacson O, Björklund A. Cholecystokinin content in the basal ganglia in Huntington's disease. The expression of cholecystokinin immunoreactivity in striatal grafts to ibotenic acid-lesioned rat striatum. Annals of the New York Academy of Sciences. 448: 488-94. PMID 3161446 DOI: 10.1111/J.1749-6632.1985.Tb29942.X  0.56
1985 Isacson O, Brundin P, Gage FH, Björklund A. Neural grafting in a rat model of Huntington's disease: progressive neurochemical changes after neostriatal ibotenate lesions and striatal tissue grafting. Neuroscience. 16: 799-817. PMID 2936982 DOI: 10.1016/0306-4522(85)90095-8  0.92
1984 Isacson O, Brundin P, Kelly PA, Gage FH, Björklund A. Functional neuronal replacement by grafted striatal neurones in the ibotenic acid-lesioned rat striatum. Nature. 311: 458-60. PMID 6482962 DOI: 10.1038/311458a0  0.92
Show low-probability matches.